“As far as immunologic damage? Oh, HHV-6A does it much more efficiently than HIV.”141 Citing data from multiple studies by diverse scientists, Knox added: “Where we have seen HHV-6A in tissue, we see dead tissue. And where you see . . . HIV alone . . . you don’t see dead tissue. You don’t see destroyed organs and scar formation, and that’s what you see when you see HHV-6A. We find replacement of the normal architecture of the lymph nodes with scar tissue. HHV-6A kills it. It kills the lymph node tissue.”142
